Targeted delivery in primary and metastatic brain tumors: Summary report of the seventh annual meeting of the blood-brain barrier disruption consortium

Nancy Doolittle, Lauren E. Abrey, Nicolay Ferrari, Walter A. Hall, Edward R. Laws, Roger E. McLendon, Leslie Muldoon, David Peereboom, Darryl R. Peterson, C. Patrick Reynolds, Peter Senter, Edward Neuwelt

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

The November 2000 NIH report of the Brain Tumor Progress Review Group identified delivering and targeting therapeutic agents as a priority in the treatment of malignant brain tumors. For this reason, the seventh annual Blood-Brain Barrier Disruption Consortium meeting, partially funded by an NIH R13 Grant, focused on recent advances in targeted delivery to the central nervous system, clinical trials for primary and metastatic brain tumors using enhanced chemotherapy delivery, and strategies to lessen the toxicities associated with dose intensive treatments, using thiols.

Original languageEnglish (US)
Pages (from-to)1702-1709
Number of pages8
JournalClinical Cancer Research
Volume8
Issue number6
StatePublished - 2002

Fingerprint

Blood-Brain Barrier
Brain Neoplasms
Sulfhydryl Compounds
Therapeutics
Central Nervous System
Clinical Trials
Drug Therapy

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Targeted delivery in primary and metastatic brain tumors : Summary report of the seventh annual meeting of the blood-brain barrier disruption consortium. / Doolittle, Nancy; Abrey, Lauren E.; Ferrari, Nicolay; Hall, Walter A.; Laws, Edward R.; McLendon, Roger E.; Muldoon, Leslie; Peereboom, David; Peterson, Darryl R.; Patrick Reynolds, C.; Senter, Peter; Neuwelt, Edward.

In: Clinical Cancer Research, Vol. 8, No. 6, 2002, p. 1702-1709.

Research output: Contribution to journalArticle

Doolittle, N, Abrey, LE, Ferrari, N, Hall, WA, Laws, ER, McLendon, RE, Muldoon, L, Peereboom, D, Peterson, DR, Patrick Reynolds, C, Senter, P & Neuwelt, E 2002, 'Targeted delivery in primary and metastatic brain tumors: Summary report of the seventh annual meeting of the blood-brain barrier disruption consortium', Clinical Cancer Research, vol. 8, no. 6, pp. 1702-1709.
Doolittle, Nancy ; Abrey, Lauren E. ; Ferrari, Nicolay ; Hall, Walter A. ; Laws, Edward R. ; McLendon, Roger E. ; Muldoon, Leslie ; Peereboom, David ; Peterson, Darryl R. ; Patrick Reynolds, C. ; Senter, Peter ; Neuwelt, Edward. / Targeted delivery in primary and metastatic brain tumors : Summary report of the seventh annual meeting of the blood-brain barrier disruption consortium. In: Clinical Cancer Research. 2002 ; Vol. 8, No. 6. pp. 1702-1709.
@article{a0c9571397ec47a685e4311aa98484e2,
title = "Targeted delivery in primary and metastatic brain tumors: Summary report of the seventh annual meeting of the blood-brain barrier disruption consortium",
abstract = "The November 2000 NIH report of the Brain Tumor Progress Review Group identified delivering and targeting therapeutic agents as a priority in the treatment of malignant brain tumors. For this reason, the seventh annual Blood-Brain Barrier Disruption Consortium meeting, partially funded by an NIH R13 Grant, focused on recent advances in targeted delivery to the central nervous system, clinical trials for primary and metastatic brain tumors using enhanced chemotherapy delivery, and strategies to lessen the toxicities associated with dose intensive treatments, using thiols.",
author = "Nancy Doolittle and Abrey, {Lauren E.} and Nicolay Ferrari and Hall, {Walter A.} and Laws, {Edward R.} and McLendon, {Roger E.} and Leslie Muldoon and David Peereboom and Peterson, {Darryl R.} and {Patrick Reynolds}, C. and Peter Senter and Edward Neuwelt",
year = "2002",
language = "English (US)",
volume = "8",
pages = "1702--1709",
journal = "Clinical Cancer Research",
issn = "1078-0432",
publisher = "American Association for Cancer Research Inc.",
number = "6",

}

TY - JOUR

T1 - Targeted delivery in primary and metastatic brain tumors

T2 - Summary report of the seventh annual meeting of the blood-brain barrier disruption consortium

AU - Doolittle, Nancy

AU - Abrey, Lauren E.

AU - Ferrari, Nicolay

AU - Hall, Walter A.

AU - Laws, Edward R.

AU - McLendon, Roger E.

AU - Muldoon, Leslie

AU - Peereboom, David

AU - Peterson, Darryl R.

AU - Patrick Reynolds, C.

AU - Senter, Peter

AU - Neuwelt, Edward

PY - 2002

Y1 - 2002

N2 - The November 2000 NIH report of the Brain Tumor Progress Review Group identified delivering and targeting therapeutic agents as a priority in the treatment of malignant brain tumors. For this reason, the seventh annual Blood-Brain Barrier Disruption Consortium meeting, partially funded by an NIH R13 Grant, focused on recent advances in targeted delivery to the central nervous system, clinical trials for primary and metastatic brain tumors using enhanced chemotherapy delivery, and strategies to lessen the toxicities associated with dose intensive treatments, using thiols.

AB - The November 2000 NIH report of the Brain Tumor Progress Review Group identified delivering and targeting therapeutic agents as a priority in the treatment of malignant brain tumors. For this reason, the seventh annual Blood-Brain Barrier Disruption Consortium meeting, partially funded by an NIH R13 Grant, focused on recent advances in targeted delivery to the central nervous system, clinical trials for primary and metastatic brain tumors using enhanced chemotherapy delivery, and strategies to lessen the toxicities associated with dose intensive treatments, using thiols.

UR - http://www.scopus.com/inward/record.url?scp=0036278836&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036278836&partnerID=8YFLogxK

M3 - Article

C2 - 12060607

AN - SCOPUS:0036278836

VL - 8

SP - 1702

EP - 1709

JO - Clinical Cancer Research

JF - Clinical Cancer Research

SN - 1078-0432

IS - 6

ER -